home All News open_in_new Full Article

Second patient death reported with gene therapy for muscular dystrophy

Shares of Sarepta Therapeutics have plunged again after the drugmaker reported a second death in connection with its gene therapy for muscular dystrophy


today 9 d. ago attach_file Events

attach_file Economics
attach_file Politics
attach_file Economics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Society
attach_file Politics
attach_file Events
attach_file Politics
attach_file Events
attach_file Politics
attach_file Events
attach_file Events
attach_file Events
attach_file Events
attach_file Politics
attach_file Events
attach_file Politics


ID: 959484602
Add Watch Country

arrow_drop_down